Scientific Program
The theme for WCBP 2026 is "Integrating Science, Regulations, and Digitalization for Global Patient-Centered Care". The Symposium brings together industry, regulatory, and academic professionals to discuss the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives. The three-day program consists of plenary and parallel sessions with speaker presentations, panel discussions, workshops, roundtables, virtual posters, an exhibit hall, and technical seminars hosted by our exhibitor partners that give you the opportunity to engage with fellow attendees in meaningful discussions on the role of current and emerging CMC analytical technology. We look forward to an informative Symposium and hope to see you there. Be ready to network, collaborate, and expand your knowledge. WCBP 2026 will discuss the following topics:
- AI in Manufacturing
- Barriers to Local GMP Manufacturing and Testing in LMICs
- Comparability
- Emerging Regulatory & Quality Expectations on Control
- Emerging Therapeutic Technologies
- ICH Guidelines on Q1 Stability Testing
- Modernizing CMC Regulatory Submissions
- Unblocking the Regulatory Barriers to Innovation
- Use of Reliance Pathways/Collaboration and Cloud Platforms to Enhance Submissions
Save the Date
Mark your calendars for WCBP 2026 on January 27-29, 2026 in Washington D.C., USA. Registration opens in September.
Frequently Asked Questions
"Great opportunity to meet the regulators from the Health Agencies from around the world and exchange ideas with them."
—Belma Ljutic, WCBP 2025 Attendee"WCBP is a great organization that sets the standard for regulatory professionals in CMC. It is the penultimate place for engaging and interacting with those at the forefront of the industry and is always a fantastic time to learn and discuss and progress as a professional."
—John Armando, WCBP 2025 Attendee